Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

Managing the breast in patients who test positive for hereditary breast cancer.

Euhus D.

Ann Surg Oncol. 2012 Jun;19(6):1738-44. doi: 10.1245/s10434-012-2258-x. Epub 2012 Mar 7. Review.

PMID:
22395981
[PubMed - indexed for MEDLINE]
2.

Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers.

MacDonald DJ, Sarna L, Uman GC, Grant M, Weitzel JN.

Oncol Nurs Forum. 2006 Nov 3;33(2):E27-35.

PMID:
16518435
[PubMed - indexed for MEDLINE]
Free Article
3.

Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting.

Morgan D, Sylvester H, Lucas FL, Miesfeldt S.

Fam Cancer. 2009;8(4):277-87. doi: 10.1007/s10689-009-9242-z. Epub 2009 Apr 4.

PMID:
19347608
[PubMed - indexed for MEDLINE]
4.

American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

American Society of Clinical Oncology.

J Clin Oncol. 2003 Jun 15;21(12):2397-406. Epub 2003 Apr 11.

PMID:
12692171
[PubMed - indexed for MEDLINE]
5.

Recognition and management of hereditary breast cancer syndromes.

Thull DL, Vogel VG.

Oncologist. 2004;9(1):13-24. Review.

PMID:
14755011
[PubMed - indexed for MEDLINE]
Free Article
6.

Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation.

Stolier AJ, Fuhrman GM, Mauterer L, Bolton JS, Superneau DW.

Breast J. 2004 Nov-Dec;10(6):475-80.

PMID:
15569201
[PubMed - indexed for MEDLINE]
7.

Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.

Kuschel B, Lux MP, Goecke TO, Beckmann MW.

Eur J Cancer Prev. 2000 Jun;9(3):139-50. Review.

PMID:
10954253
[PubMed - indexed for MEDLINE]
8.

Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation.

Contant CM, Menke-Pluijmers MB, Seynaeve C, Meijers-Heijboer EJ, Klijn JG, Verhoog LC, Tjong Joe Wai R, Eggermont AM, van Geel AN.

Eur J Surg Oncol. 2002 Sep;28(6):627-32.

PMID:
12359199
[PubMed - indexed for MEDLINE]
9.

Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.

Uyei A, Peterson SK, Erlichman J, Broglio K, Yekell S, Schmeler K, Lu K, Meric-Bernstam F, Amos C, Strong L, Arun B.

Cancer. 2006 Dec 15;107(12):2745-51.

PMID:
17109443
[PubMed - indexed for MEDLINE]
Free Article
10.

Breast cancer and ovarian cancer genetics.

Edlich RF, Winters KL, Lin KY.

J Long Term Eff Med Implants. 2005;15(5):533-45. Review.

PMID:
16218901
[PubMed - indexed for MEDLINE]
11.

Management of women at increased risk for hereditary breast cancer.

Smith KL, Isaacs C.

Breast Dis. 2006-2007;27:51-67. Review.

PMID:
17917140
[PubMed - indexed for MEDLINE]
12.

Hereditary breast cancer and handling of patients at risk.

Eerola H, Aittomäki K, Asko-Seljavaara S, Nevanlinna H, von Smitten K.

Scand J Surg. 2002;91(3):280-7. Review.

PMID:
12449472
[PubMed - indexed for MEDLINE]
13.
14.

Risk-reducing mastectomy.

Edlich RF, Winters KL, Faulkner BC, Lin KY.

J Long Term Eff Med Implants. 2006;16(4):301-14. Review.

PMID:
17073572
[PubMed - indexed for MEDLINE]
15.

Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.

Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT.

Gynecol Oncol. 2005 May;97(2):457-67.

PMID:
15863145
[PubMed - indexed for MEDLINE]
16.

Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.

Roukos DH, Briasoulis E.

Nat Clin Pract Oncol. 2007 Oct;4(10):578-90. Review.

PMID:
17898808
[PubMed - indexed for MEDLINE]
17.

One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).

Lodder LN, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JG, Seynaeve C, van Geel AN, Tilanus MM, Bartels CC, Verhoog LC, Brekelmans CT, Burger CW, Niermeijer MF.

Breast Cancer Res Treat. 2002 May;73(2):97-112.

PMID:
12088120
[PubMed - indexed for MEDLINE]
18.

Clinical, pathological and genetic features of women at high familial risk of breast cancer undergoing prophylactic mastectomy.

Scott CI, Iorgulescu DG, Thorne HJ, Henderson MA, Phillips KA; Kathleen Cuningham Foundation Consortium for Familial Breast Cancer (kConFab).

Clin Genet. 2003 Aug;64(2):111-21.

PMID:
12859406
[PubMed - indexed for MEDLINE]
19.

Identifying and managing hereditary risk of breast and ovarian cancer.

Frank TS, Critchfield GC.

Clin Perinatol. 2001 Jun;28(2):395-406. Review.

PMID:
11499060
[PubMed - indexed for MEDLINE]
20.

The prevention of hereditary breast cancer.

Rodriquez E, Domchek SM.

Semin Oncol. 2007 Oct;34(5):401-5. Review.

PMID:
17920894
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk